- Home
- ALXO vs SXTC Comparison
ALXO vs SXTC Comparison
Compare ALXO & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- SXTC
- Stock Information
- Founded
- ALXO 2015
- SXTC 2005
- Country
- ALXO United States
- SXTC China
- Employees
- ALXO N/A
- SXTC N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- SXTC Biotechnology: Pharmaceutical Preparations
- Sector
- ALXO Health Care
- SXTC Health Care
- Exchange
- ALXO Nasdaq
- SXTC Nasdaq
- Market Cap
- ALXO 24.0M
- SXTC 25.5M
- IPO Year
- ALXO 2020
- SXTC 2019
- Fundamental
- Price
- ALXO $0.56
- SXTC $1.32
- Analyst Decision
- ALXO Strong Buy
- SXTC
- Analyst Count
- ALXO 6
- SXTC 0
- Target Price
- ALXO $3.30
- SXTC N/A
- AVG Volume (30 Days)
- ALXO 456.6K
- SXTC 2.4M
- Earning Date
- ALXO 05-08-2025
- SXTC 01-01-0001
- Dividend Yield
- ALXO N/A
- SXTC N/A
- EPS Growth
- ALXO N/A
- SXTC N/A
- EPS
- ALXO N/A
- SXTC 20.77
- Revenue
- ALXO N/A
- SXTC $1,818,404.00
- Revenue This Year
- ALXO N/A
- SXTC N/A
- Revenue Next Year
- ALXO N/A
- SXTC N/A
- P/E Ratio
- ALXO N/A
- SXTC $0.07
- Revenue Growth
- ALXO N/A
- SXTC 6.78
- 52 Week Low
- ALXO $0.41
- SXTC $0.95
- 52 Week High
- ALXO $10.97
- SXTC $11.92
- Technical
- Relative Strength Index (RSI)
- ALXO 59.08
- SXTC 41.43
- Support Level
- ALXO $0.44
- SXTC $1.34
- Resistance Level
- ALXO $0.48
- SXTC $1.76
- Average True Range (ATR)
- ALXO 0.05
- SXTC 0.23
- MACD
- ALXO 0.02
- SXTC -0.01
- Stochastic Oscillator
- ALXO 99.16
- SXTC 15.71
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.